Previous Article | Next Article ![]()
Infect. Immun., Jul 1997, 2732-2739, Vol 65, No. 7
GR Thomas, M McCrossan and ME Selkirk
The susceptibility of Brugia malayi microfilariae and adults to injury by
the murine macrophage cell line J774 activated with gamma interferon and
bacterial lipopolysaccharide has been examined in vitro. Parasites of both
stages showed a decline in viability over 48 h of coculture with activated
macrophages, assessed by their capacity to reduce the tetrazolium salt
3-[4,5-diethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), although
adult parasites were more resistant than microfilariae. Removal of
parasites to cell-free medium following exposure to activated macrophages
for up to 48 h resulted in partial recovery of their capacity to reduce
MTT, suggesting that the effects were primarily cytostatic. However,
prolonged exposure to activated J774 cells for 72 h resulted in parasite
death. Addition of the nitric oxide synthase inhibitor L-NMMA
(N(G)-monomethyl-L-arginine monoacetate) indicated that nitric oxide
derivatives were responsible for cytostasis and ultimate toxicity. The
toxicity of nitric oxide derivatives was confirmed by coincubation of
parasites with chemical donors, although far higher concentrations were
required than those generated by activated J774 cells, implying additional
complexity in macrophage-mediated cytotoxicity. These experiments further
suggested that peroxynitrite or its by-products were more potently damaging
to filariae than nitric oxide per se. Examination of ultrastructural
changes on exposure of parasites to activated macrophages or donors of
nitric oxide indicated that hypodermal mitochondria were highly vacuolated,
with less prominent cristae. The data are discussed with reference to
immunity to lymphatic filariae and their mechanisms of energy generation.
Copyright © 1997, American Society for Microbiology
Cytostatic and cytotoxic effects of activated macrophages and nitric oxide donors on Brugia malayi
Department of Biochemistry, Imperial College of Science, Technology and Medicine, London, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|